Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 473-390-7 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Repeated dose toxicity: inhalation
Administrative data
- Endpoint:
- sub-chronic toxicity: inhalation
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Study period:
- 12 March 1992 to 27 July 1992
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Study conducted under GLP conditions
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 993
- Report date:
- 1993
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 413 (Subchronic Inhalation Toxicity: 90-Day Study)
- GLP compliance:
- yes
- Limit test:
- yes
Test material
- Reference substance name:
- T-5452
- IUPAC Name:
- T-5452
- Test material form:
- other: Liquid
- Details on test material:
- - Name of test material (as cited in study report: T-5452
- Substance type: Colourless liquid
- Physical state: Liquid
- Lot/batch no.: 102
- Storage condition of test material: Ambient in steel drums supplied
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: Sprague-Dawley CD
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River (U.S.A.) Ltd., Portage, Michigan, U.S.A.
- Age at study initiation: Approximately 6 weeks
- Weight at study initiation: Males: 234-238 g, Females: 187-190 g
- Fasting period before study: No data
- Housing: 5 of the same sex to a cage in suspended cages with stainless steel sides and stainless steel mesh floors.
- Diet (e.g. ad libitum): SDS Rat and Mouse No. 1 modified diet (Special Diets Services, Witham, Essex, England) ad libitum.
- Water (e.g. ad libitum): Tap water ad libitum.
- Acclimation period: 2 weeks
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 18-26
- Humidity (%): 37-61
- Air changes (per hr): No data
- Photoperiod (hrs dark / hrs light): 12-12
IN-LIFE DATES: From: 12 March 1992 To: 27 July 1992
Administration / exposure
- Route of administration:
- inhalation: vapour
- Type of inhalation exposure:
- whole body
- Vehicle:
- other: no vehicle
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: Vapour was produced by metering the liquied from a central pressurised reservoir, mounted on a load cell, to a helical copper tube immerced in a water bath maintained at 80 C. Vapour emerging from the tube was mixed with air which had been pre-warmed by being passed at a rate of 40 L/min through a second copper tube, also immersed in the water bath. The vapour/air mixture was passed through a nylon tube to the base of a glass column where it was mixed with diluent air introduced at a rate of 110 L/min. A serparate reservoir and vaporiser was used for each dose level.
- Method of holding animals in test chamber: Rats were held within individual compartments of stainless steel wire mesh cages during exposure.
- Source and rate of air: Pre-warmed air at a rate of 40 L/min (vapour) and prewarmed air at 110 L/min (diluent air).
- Method of conditioning air: Water bath.
- System of generating particulates/aerosols:
- Temperature, humidity, pressure in air chamber: Approx. 23.5-24.5 C, Approx. 31-45 % RH, 10 mm of water below ambient.
- Air flow rate: 150 L/min total
- Air change rate: No data.
TEST ATMOSPHERE
- Brief description of analytical method used: Atmospheres were monitored throughout exposure by Miran 1A-CVF infra-red gas analysers.
- Samples taken from breathing zone: no data - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- Atmospheres were monitored throughout exposure by Miran 1A-CVF infra-red gas analysers.
- Duration of treatment / exposure:
- 6 hours per exposure
- Frequency of treatment:
- 5 days a week for 13 weeks
Doses / concentrations
- Remarks:
- Doses / Concentrations:
4971 ppm, 15094 ppm, and 49589 ppm
Basis:
analytical conc.
- No. of animals per sex per dose:
- 10
- Control animals:
- yes, concurrent no treatment
- Details on study design:
- - Dose selection rationale: No data
- Rationale for selecting satellite groups: Randomly by a computer program.
- Post-exposure recovery period in satellite groups: 4 weeks - Positive control:
- None
Examinations
- Observations and examinations performed and frequency:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: Twice daily, prior to loading and immediately following unloading from the chambers on exposure days.
- Cage side observations checked in appendix 4 were included.
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: Twice daily, prior to loading and immediately following unloading from the chambers on exposure days.
BODY WEIGHT: Yes
- Time schedule for examinations: At group allocation, them weekly, commecing 1 week before the start of dosing and continuing throughout the study.
FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study):
- Food consumption for each cage of rats was recorded weekly commencing one week prior to the start of exposures until the end of the study.
- Compound intake calculated as time-weighted averages from the consumption and body weight gain data: No data
OPHTHALMOSCOPIC EXAMINATION: Yes
- Time schedule for examinations: All rats examined prior to allocation.
- Dose groups that were examined: All
HAEMATOLOGY: Yes
- Time schedule for collection of blood: During week 13 (main group), week 17 for satellite group.
- Anaesthetic used for blood collection: Yes (ether).
- Animals fasted: Yes, overnight.
- How many animals: All animals.
- Parameters checked in table 8 were examined.
CLINICAL CHEMISTRY: Yes
- Time schedule for collection of blood: During week 13 (main group), week 17 for satellite group.
- Animals fasted: Yes, overnight
- How many animals: All animals.
- Parameters checked in table 9 were examined.
URINALYSIS: No
NEUROBEHAVIOURAL EXAMINATION: No - Sacrifice and pathology:
- GROSS PATHOLOGY: Yes
HISTOPATHOLOGY: Yes - Statistics:
- All analyses were carried out separately for males and females.
(i) If the data consisted predominantly of one particular value (relative frequency of the mode
exceeds 75 %) the proportion of animals with values different from the mode was analysed by
appropriate methods. Otherwise:
(ii) Bartlett's test (1) was applied to test for heterogeneity of variance between treatment; where
significant (at the 1% level) heterogeneity was found, a logarithmic transformation was tried
to see ifa more stable variance structure could be obtained.
(iii) If no significant heterogeneity was detected (or if a satisfactory transformation was found), a
one-way analysis of variance was carried out. If significant heterogeneity of variance was
present, and could not be removed by a transformation, the Kruskal-Wallis analysis of ranks
(2) was used.
(iv) Except 'for pre-exposure data, analyses of variance were followed by Student's; 't' test and
Williams' test (3) for a dose-related response, although only Williams' test was reported. The
Kruskal--Wallis analyses were followed by Shirley's test (4), the non-parametric equivalent of
the 't' and Williams' tests.
Results and discussion
Results of examinations
- Clinical signs:
- no effects observed
- Mortality:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- no effects observed
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- no effects observed
- Haematological findings:
- no effects observed
- Clinical biochemistry findings:
- no effects observed
- Urinalysis findings:
- not examined
- Behaviour (functional findings):
- not examined
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Gross pathological findings:
- no effects observed
- Histopathological findings: non-neoplastic:
- no effects observed
- Histopathological findings: neoplastic:
- not examined
- Details on results:
- CLINICAL SIGNS AND MORTALITY: No abnormal clinical signs were observed. Rat no. 70 from the control group died in the holding cage before exposure during week 9 of the study. The cause of death is unknown.
BODY WEIGHT AND WEIGHT GAIN: No treatement related effects were observed.
FOOD CONSUMPTION AND COMPOUND INTAKE: No treatement related effects were observed.
OPHTHALMOSCOPIC EXAMINATION: No treatement related effects were observed.
HAEMATOLOGY: No treatement related effects were observed.
CLINICAL CHEMISTRY: No treatement related effects were observed.
ORGAN WEIGHTS: No treatement related effects were observed.
GROSS PATHOLOGY: No treatement related effects were observed.
HISTOPATHOLOGY: NON-NEOPLASTIC: No treatement related effects were observed.
Effect levels
- Dose descriptor:
- NOAEL
- Effect level:
- ca. 49 589 ppm (analytical)
- Sex:
- male/female
- Basis for effect level:
- other: overall effects clinical signs; mortality; body weight; food consumption; ophthalmoscopic examination; haematology; clinical chemistry; gross pathology; organ weights; histopathology
Target system / organ toxicity
- Critical effects observed:
- not specified
Any other information on results incl. tables
Analogue substance info is referenced in the Category Reporting Format---> attached in section 13.
Applicant's summary and conclusion
- Conclusions:
- The No Observed Adverse Effect Level for the test article under the conditions of the study was 49589 ppm.
- Executive summary:
Perfluoro-N-methylmorpoline has been used as a Read Across-Analogue to derive a NOAEL for FC-770 Repeat Dose Inhalation requirement. The target and the source molecule are both members of a category of chemicals referred to as ‘Perfluoro-compounds C5 through C18'. PFCs are inert fluids composed of a complex combination of organic compounds resulting from the distillation of electrochemically fluorinated (ECF) compounds. This class consists of branched, linear and cyclic perfluorinated hydrocarbons having carbon numbers predominantly in the range of C5-C18 and boiling in the range of approximately 25 C to 255 C (77 F – 491 F). Perfluorinated amine and ether compounds may also be present. The compounds within this class of materials are all fully fluorinated and do not contain functional groups. As such, the materials within this class are all chemically and biologically inert. PFCs have high Henry’s constants which dictates, their low potential for interaction with biological membranes. The available data on this class of material demonstrates very consistent properties with regard to human health and environmental impact. The commonalities within this class are not surprising given the underlying physical/chemical properties
The 90 day inhalation toxicity of the test article was tested in Sprague-Dawley CD rats. Rats were whole-body exposed to the test article for 6 hour a day, 5 days a week, for 13 weeks at dose levels of 4971, 15094, and 49589 ppm. Control rats were similarly exposed to air on the same schedule. A satellite group was observed for an additional 4 weeks after sacrifice of the main group. Clinical signs were recorded twice daily, usually prior to loading and immediately following unloading from the chambers on exposure days. Body weights were recorded at group allocation, then weekly commencing one week prior to the start of exposures until the end of study. The quantity of food consumed by each cage of rats was recorded weekly commencing one week prior to the start of exposures until the end of the study. The eyes of all rats were examined prior to allocation and at study conclusion. Blood samples (fasted) were taken from all main group rats during week 13 and from the satellite group on week 17. Haematology and clinical chemistry parameters were examined from the blood samples. At week 13 (main group) and week 17 (satellite group) the animals were sacrificed and subject to gross necropsy. Microscopic examination of the tissues listed in Table 11 was also conducted. No treatment related changes in any parameters were observed due to test article exposure. The No Observed Adverse Effect Level for the test article under the conditions of the study was 49589 ppm.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.